Dominique J Lunter
Overview
Explore the profile of Dominique J Lunter including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
20
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lenhart J, Lunter D
Eur J Pharm Biopharm
. 2024 Sep;
204:114501.
PMID: 39278333
Production of patient-specific dosage forms is important to improve patient adherence and effectiveness while reducing the prevalence and severity of adverse effects. Due to its possibility of rapid prototyping 3D...
2.
Lenhart J, Postges F, Wagner K, Lunter D
Pharmaceutics
. 2024 Apr;
16(4).
PMID: 38675214
Fused deposition modeling (FDM) is a rather new technology in the production of personalized dosage forms. The melting and printing of polymer-active pharmaceutical ingredient (API)-mixtures can be used to produce...
3.
Postges F, Lenhart J, Stoyanov E, Lunter D, Wagner K
Int J Pharm X
. 2024 Jan;
6:100222.
PMID: 38162398
As performance of ternary amorphous solid dispersions (ASDs) depends on the solid-state characteristics and polymer mixing, a comprehensive understanding of synergistic interactions between the polymers in regard of dissolution enhancement...
4.
Mitrovic J, Divovic-Matovic B, Knutson D, Petkovic M, Djorovic D, Randjelovic D, et al.
Int J Pharm
. 2023 Jan;
633:122613.
PMID: 36657554
Preclinical development of deuterated pyrazoloquinolinone ligands, promising drug candidates for various neuropsychiatric disorders, was hindered by unusually low solubility in water and oils. DK-I-60-3 (7-methoxy-d3-2-(4-methoxy-d3-phenyl)-2,5-dihydro-3Hpyrazolo[4,3-c]quinolin-3-one) is one of such pyrazoloquinolinones,...
5.
Heck R, Lukic M, Savic S, Daniels R, Lunter D
Eur J Pharm Sci
. 2017 May;
106:34-40.
PMID: 28546105
Aim: The purpose of this study was to evaluate skin permeation and penetration of nonivamide which has been formulated in novel film-forming formulations (FFFs). These formulations aim to prolong the...
6.
Film-forming formulations containing porous silica for the sustained delivery of actives to the skin
Heck R, Hermann S, Lunter D, Daniels R
Eur J Pharm Biopharm
. 2016 Aug;
108:1-8.
PMID: 27553263
The purpose of this study was to develop film-forming formulations facilitating long-term treatment of chronic pruritus with capsaicinoids. To this end, an oily solution of nonivamide was loaded into porous...